Biotechnology. Ancillary materials present during the production of cellular therapeutic products - Best practice guidance for ancillary material users Ingestion-build-98192 Medical institutions and organisations

Medical institutions and organisations

It also applies to hollow sections formed hot with or without subsequent heat treatment or formed cold with subsequent heat treatment to obtain equivalent metallurgical conditions to

Annex B (informative) Example of a report — Sampling from groundwaters

as defined in BS EN ISO 11553-1:2008

2 Fixings and materials not supplied by the manufacturer

Biotechnology. Ancillary materials present during the production of cellular therapeutic products - Best practice guidance for ancillary material users Ingestion-build-98192 Medical institutions and organisationsWhat is this standard about? This document provides guidance for ancillary material (AM) users. It is applicable to cellular therapeutic products, including those gene therapy products whereby cells form part of the final product. It does not apply to products without cells. This document focuses primarily on ancillary materials (AMs) of biological (human and animal) origin and their potential impurities and contaminants. NOTE 1 The decision chart in